These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 2013329)
1. Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo. Towatari T; Nikawa T; Murata M; Yokoo C; Tamai M; Hanada K; Katunuma N FEBS Lett; 1991 Mar; 280(2):311-5. PubMed ID: 2013329 [TBL] [Abstract][Full Text] [Related]
2. Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro. Murata M; Miyashita S; Yokoo C; Tamai M; Hanada K; Hatayama K; Towatari T; Nikawa T; Katunuma N FEBS Lett; 1991 Mar; 280(2):307-10. PubMed ID: 2013328 [TBL] [Abstract][Full Text] [Related]
3. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors. Tsuchiya K; Kohda Y; Yoshida M; Zhao L; Ueno T; Yamashita J; Yoshioka T; Kominami E; Yamashima T Exp Neurol; 1999 Feb; 155(2):187-94. PubMed ID: 10072294 [TBL] [Abstract][Full Text] [Related]
4. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells. Montaser M; Lalmanach G; Mach L Biol Chem; 2002; 383(7-8):1305-8. PubMed ID: 12437121 [TBL] [Abstract][Full Text] [Related]
5. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Barrett AJ; Kembhavi AA; Brown MA; Kirschke H; Knight CG; Tamai M; Hanada K Biochem J; 1982 Jan; 201(1):189-98. PubMed ID: 7044372 [TBL] [Abstract][Full Text] [Related]
6. Rat liver thiol proteinases: cathepsin B, cathepsin H and cathepsin L. Katunuma N; Towatari T; Kominami E; Hashida S; Takio K; Titani K Acta Biol Med Ger; 1981; 40(10-11):1419-25. PubMed ID: 6177136 [TBL] [Abstract][Full Text] [Related]
7. Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo. Hashida S; Towatari T; Kominami E; Katunuma N J Biochem; 1980 Dec; 88(6):1805-11. PubMed ID: 7462205 [TBL] [Abstract][Full Text] [Related]
8. Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases. Martichonok V; Plouffe C; Storer AC; Ménard R; Jones JB J Med Chem; 1995 Aug; 38(16):3078-85. PubMed ID: 7636871 [TBL] [Abstract][Full Text] [Related]
9. E-64 [L-trans-epoxysuccinyl-leucyl-amido(4-guanidino)butane] and related epoxides as inhibitors of cysteine proteinases. Barrett AJ; Kembhavi AA; Hanada K Acta Biol Med Ger; 1981; 40(10-11):1513-7. PubMed ID: 7044005 [TBL] [Abstract][Full Text] [Related]
10. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B. Crawford C; Mason RW; Wikstrom P; Shaw E Biochem J; 1988 Aug; 253(3):751-8. PubMed ID: 2845932 [TBL] [Abstract][Full Text] [Related]
11. Cathepsins B and L in synovial fluids from patients with rheumatoid arthritis and the effect of cathepsin B on the activation of pro-urokinase. Ikeda Y; Ikata T; Mishiro T; Nakano S; Ikebe M; Yasuoka S J Med Invest; 2000 Feb; 47(1-2):61-75. PubMed ID: 10740981 [TBL] [Abstract][Full Text] [Related]
12. Cathepsin B-like activity predominates over cathepsin L-like activity in adult Schistosoma mansoni and S. japonicum. Caffrey CR; Ruppel A Parasitol Res; 1997; 83(6):632-5. PubMed ID: 9211519 [TBL] [Abstract][Full Text] [Related]
13. Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors. Schaschke N; Assfalg-Machleidt I; Machleidt W; Moroder L FEBS Lett; 1998 Jan; 421(1):80-2. PubMed ID: 9462845 [TBL] [Abstract][Full Text] [Related]
14. Effects of selective inhibition of cathepsin B and general inhibition of cysteine proteinases on lysosomal proteolysis in rat liver in vivo and in vitro. Ohshita T; Nikawa T; Towatari T; Katunuma N Eur J Biochem; 1992 Oct; 209(1):223-31. PubMed ID: 1382984 [TBL] [Abstract][Full Text] [Related]
15. Epoxysuccinyl dipeptides as selective inhibitors of cathepsin B. Gour-Salin BJ; Lachance P; Plouffe C; Storer AC; Ménard R J Med Chem; 1993 Mar; 36(6):720-5. PubMed ID: 8459399 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64. Navab R; Mort JS; Brodt P Clin Exp Metastasis; 1997 Mar; 15(2):121-9. PubMed ID: 9062388 [TBL] [Abstract][Full Text] [Related]
17. Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B. Lynas JF; Hawthorne SJ; Walker B Bioorg Med Chem Lett; 2000 Aug; 10(15):1771-3. PubMed ID: 10937745 [TBL] [Abstract][Full Text] [Related]
18. Suppressive effect of N-(benzyloxycarbonyl)-L-phenylalanyl-L-tyrosinal on bone resorption in vitro and in vivo. Woo JT; Yamaguchi K; Hayama T; Kobori T; Sigeizumi S; Sugimoto K; Kondo K; Tsuji T; Ohba Y; Tagami K; Sumitani K Eur J Pharmacol; 1996 Apr; 300(1-2):131-5. PubMed ID: 8741178 [TBL] [Abstract][Full Text] [Related]
19. WF14865A and B, new cathepsins B and L inhibitors produced by Aphanoascus fulvescens. I. Taxonomy, production, purification and biological properties. Otsuka T; Muramatsu Y; Nakanishi T; Hatanaka H; Okamoto M; Hino M; Hashimoto S J Antibiot (Tokyo); 2000 May; 53(5):449-58. PubMed ID: 10908107 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64. Tamai M; Matsumoto K; Omura S; Koyama I; Ozawa Y; Hanada K J Pharmacobiodyn; 1986 Aug; 9(8):672-7. PubMed ID: 3023601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]